Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 2:32 AM
Ignite Modification Date:
2025-12-26 @ 1:08 AM
NCT ID:
NCT00905034
Group ID:
EG000
Title:
MOAD
Description:
Chemotherapy regimen of methotrexate, rituximab, vincristine, pegylated L-asparaginase and dexamethasone (MOAD). Methotrexate 200 mg/m\^2 intravenous (IV) days 1 and 15, Vincristine 1.4 mg/m\^2 IV days 1, 8 and 15; PEG-l-asparaginase 2500 International units/m\^2 IV days 2 and 16; Dexamethasone 40 mg/day IV or oral days 1-4 \& 15-18; Rituximab 375 mg/m\^2 IV days 1 \& 15 (first 4 cycles) for participants CD20 positive or positive by immunostain.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
33
Serious Number At Risk:
37
Other Number Affected:
37
Other Number At Risk:
37
Study:
NCT00905034
Results Section:
NCT00905034
Adverse Events Module:
NCT00905034